Narrow search
Showing 1 - 10 of 132,217
Cover Image
In search of the missing hand of 'collaborative action' : evidence from the Indian medical device industry
Kale, Dinar; Wield, David V. - In: Innovation and development : RIAD 9 (2019) 1, pp. 1-23
Persistent link: https://www.econbiz.de/10012156951
Cover Image
Market menagerie : health and development in late industrial states
Srinivas, Smita - 2012
Persistent link: https://www.econbiz.de/10009536124
Cover Image
Outsourcing biopharma R&D to India
Chowdhury, Probir Roy - 2011
Persistent link: https://www.econbiz.de/10009491476
Cover Image
India's healthcare industry : innovation in delivery, financing, and manufacturing
Burns, Lawton R. (ed.) - 2014 - 1. publ.
India's healthcare industry : a system perspective / Lawton R. Burns -- Innovative responses to the healthcare … challenges confronting India / Stephen M. Sammut -- India's healthcare industry : an overview of the value chain / Lawton R …. Burns -- The medical profession in India / Ajay Bakshi, Lawton R. Burns -- India's hospital sector : the journey from public …
Persistent link: https://www.econbiz.de/10010399563
Cover Image
WTO and intellectual property rights
Sabanna, Talwar (contributor) - 2008
Persistent link: https://www.econbiz.de/10003431056
Cover Image
Patents and biopharmaceuticals in India : emerging issues
Lalitha, N.; Joseph, Diana - 2006
Persistent link: https://www.econbiz.de/10003399808
Cover Image
Market Menagerie : Health and Development in Late Industrial States
Srinivas, Smita - 2020
Market Menagerie examines technological advance and market regulation in the health industries of nations such as India …
Persistent link: https://www.econbiz.de/10014479494
Cover Image
Market Menagerie : Health and Development in Late Industrial States
Srinivas, Smita - 2012
, and other institutions interact within the health industry--using India as a primary case study. …
Persistent link: https://www.econbiz.de/10012689321
Cover Image
Pharmaceutical Biotechnology and the Related IPR Concerns, Government Policy in India
Kumar, Pankaj - 2014
Most of the medicines available in market are generic in nature and has no valid patent. Their patent has either expired or not enforced. Therefore, any pharmaceutical or biotechnological company may take this as an opportunity to manufacture and sell such un-patented medicines in both national...
Persistent link: https://www.econbiz.de/10013047391
Cover Image
India - The Next R&D Cluster for Biopharmaceuticals?
Maghrour, Abtin - 2014
developing countries are trying their best to move up the value chain. A country like India has some essential advantages in … indicate whether India has the potential to become an R&D cluster for biopharmaceuticals …
Persistent link: https://www.econbiz.de/10014039578